Status:
ACTIVE_NOT_RECRUITING
Using Liquid Biopsy in Newly Diagnosed Patients With High Grade Adenocarcinoma of Ovarian Origin, Fallopian Tubes or Primary Peritoneal
Lead Sponsor:
Institut de Cancérologie de Lorraine
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
BOVARY-CE is a monocentric, pilot, longitudinal, real-life study with a total duration of 36 months. The purpose of this study is to assess the feasibility of using liquid biopsy as a substitute for t...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Patient with non-treated high grade serous and endometrioid carcinoma of ovarian, fallopian tube, or primary peritoneal origin proven cytologically or histologically at inclusion and eligible for treatment
- Patient eligible for an upfront surgery or pretherapeutic coelioscopy
- Adequate haemoglobin rate ≥ 9 g/dL
- Patient affiliated to a social security scheme
- Ability to provide written informed consent
Exclusion
- Age \< 18 years
- Any concurrent severe and/or uncontrolled medical conditions which could compromise participation in the study
- Contraindication to blood samples of 20 mL
- Pregnant or breast-feeding women
- Ongoing treatment for the newly diagnosed cancer or the recurrence
- Other cancers treated within the last 5 years
- Patient under guardianship or curatorship or deprived of liberty
Key Trial Info
Start Date :
July 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04511988
Start Date
July 17 2021
End Date
July 1 2026
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut de Cancerologie de Lorraine
Vandœuvre-lès-Nancy, France, 54506